Arrowstreet Capital
PGEN icon

Arrowstreet Capital’s Precigen PGEN Stock Holding History

Arrowstreet Capital’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
1,788,235
+1,392,540
+352% +$6.02M ﹤0.01% 1067
2026
Q1 		$1.53M Buy
+395,695
New +$1.62M ﹤0.01% 1460
2016
Q1 		– Sell
-78,601
Closed -$2.35M – 1481
2015
Q4 		$2.35M Buy
+78,601
New +$2.65M 0.01% 753
2015
Q3 		– Sell
-32,389
Closed -$1.57M – 1460
2015
Q2 		$1.57M Buy
+32,389
New +$1.37M 0.01% 698

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital's PGEN Position: Q2 2026 in Review

Arrowstreet Capital increased its Precigen (PGEN) stake by 352% in Q2 2026, buying an estimated $6.02M and bringing the position to 1,788,235 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Arrowstreet Capital first reported a position in PGEN in Q2 2015 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Arrowstreet Capital held 1,788,235 shares of Precigen worth $10.2M as of Q2 2026.
  • Arrowstreet Capital bought 1,392,540 Precigen shares in Q2 2026, an estimated $6.02M.
  • Precigen made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1067 holding.
  • Arrowstreet Capital first reported a position in Precigen in Q2 2015 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.